Ticagrelor Tablets

NewClosedclinicalOpportunity

Build pursuit package

Key dates

Response due

August 3, 2026

Posted: July 30, 2026

Details

Buyer: Nac Pharmaceuticals (36E797)
Agency: Nac Pharmaceuticals (36E797)
Buyer type: Federal
Jurisdiction: the United States (US)
Category: Clinical
Value: —
Set-aside: —
NAICS: 325412
PSC: 6505
Source: sam.gov

Who is this buyer

Nac Pharmaceuticals (36E797)

Organization

Source: Provider universe

Not matched to a provider record yet.

Buying history

Source: Solicitation records

Records9 total
Opportunities / awards5 / 0
Value range$1,932,252 – $436,529,696
ActiveJune 10, 2026 – August 13, 2026

What they buy

Clinical (9)

Financial highlights

Source: IRS Form 990

No 990 filing on record.

Who holds their work today

Source: Solicitation records · awards

No awards on record for this buyer.

What they're trying to solve

Source: AI-generated

No brief written for this buyer yet.

Also open from this buyer

Source: Solicitation records

Ways to meet this buyer

Source: Solicitation records · event notices

Upcoming

No upcoming events on record.

View source document →

Source link on sam.gov.

← Back to all contracts